6 February 2018
Innovative strategies for intervertebral disc regenerative medicine: From cell therapies to multiscale delivery systems
As our understanding of the physiopathology of intervertebral disc (IVD) degeneration has improved, novel therapeutic
6 February 2018
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is an incurable X-linked muscle-wasting disease caused by mutations in the
6 February 2018
Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease
Pompe disease is a lysosomal storage disorder caused by acid-α-glucosidase (GAA) deficiency, leading to glycogen
6 February 2018
Neu5Gc and α1-3 GAL Xenoantigen Knockout Does Not Affect Glycemia Homeostasis and Insulin Secretion in Pigs
Xenocell therapy from neonate or adult pig pancreatic islets is one of the most promising
6 February 2018
Polymeric mannosides prevent DC-SIGN-mediated cell-infection by cytomegalovirus
Human cytomegalovirus (HCMV) is a beta-herpesvirus with a high prevalence in the population. HCMV is
6 February 2018
Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle
After intra-arterial delivery in the dystrophic dog, allogeneic muscle-derived stem cells, termed MuStem cells, contribute